Although these findings highlight the role of the mast cell-MRGPRX2 axis in causing anaphylaxis and inflammation associated with urticaria, asthma and rosacea, there is limited information available on how MRGPRX2 can be targeted to prevent these adverse reactions/diseases in humans. Here, MRGPRX2 is linked to anaphylaxis.